Protagonist Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

NEWARK, Calif.: NEWARK, Calif., Nov. 3, 2021 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today reported its financial results for the third quarter ended September 30, 2021 and provided a corporate update. "We are excited to share the substantial progress made thus far in all of...

Click to view original post